Moberg Pharma AB Statistics
Total Valuation
MBGPF has a market cap or net worth of 48.09 million. The enterprise value is 21.98 million.
| Market Cap | 48.09M |
| Enterprise Value | 21.98M |
Important Dates
The next estimated earnings date is Tuesday, February 17, 2026.
| Earnings Date | Feb 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 47.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +41.02% |
| Shares Change (QoQ) | +3.57% |
| Owned by Insiders (%) | 5.94% |
| Owned by Institutions (%) | 59.58% |
| Float | 42.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.26 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.80 |
| EV / Sales | 15.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.14, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.14 |
| Quick Ratio | 15.81 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,691.01 |
Financial Efficiency
Return on equity (ROE) is -32.11% and return on invested capital (ROIC) is -75.24%.
| Return on Equity (ROE) | -32.11% |
| Return on Assets (ROA) | -25.02% |
| Return on Invested Capital (ROIC) | -75.24% |
| Return on Capital Employed (ROCE) | -48.37% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 221,042 |
| Profits Per Employee | -4.56M |
| Employee Count | 6 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 1.00 |
Taxes
| Income Tax | -6.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +10.00% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.05 |
| Relative Strength Index (RSI) | 51.45 |
| Average Volume (20 Days) | 15,316 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MBGPF had revenue of 1.33 million and -27.36 million in losses. Loss per share was -0.58.
| Revenue | 1.33M |
| Gross Profit | 694,273 |
| Operating Income | -34.81M |
| Pretax Income | -34.28M |
| Net Income | -27.36M |
| EBITDA | -34.75M |
| EBIT | -34.81M |
| Loss Per Share | -0.58 |
Balance Sheet
The company has 25.07 million in cash and 313,495 in debt, with a net cash position of 24.75 million.
| Cash & Cash Equivalents | 25.07M |
| Total Debt | 313,495 |
| Net Cash | 24.75M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 71.84M |
| Book Value Per Share | 1.53 |
| Working Capital | 24.83M |
Cash Flow
| Operating Cash Flow | -1.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 52.35% |
| Operating Margin | -2,625.04% |
| Pretax Margin | -2,584.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBGPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.02% |
| Shareholder Yield | -41.02% |
| Earnings Yield | -56.89% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MBGPF has an Altman Z-Score of 14.07 and a Piotroski F-Score of 2.
| Altman Z-Score | 14.07 |
| Piotroski F-Score | 2 |